CDT Equity Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CDT Nasdaq 2830 www.cdtequity.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CDT Equity Inc.

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane - Jul 20th, 2026 6:30 am
CDT Equity Inc. Announces Reverse Stock Split - Jul 16th, 2026 6:00 am
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development - Jun 26th, 2026 6:30 am
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing - Jun 18th, 2026 6:30 am
CDT Equity Announces Debt Update and New Loan Facility - Jun 16th, 2026 6:30 am
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - May 28th, 2026 2:15 pm
CDT Announces Canadian Patent for AZD5904 in Male Infertility - May 27th, 2026 6:00 am
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - May 11th, 2026 2:01 pm
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - May 7th, 2026 6:30 am
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - May 6th, 2026 6:30 am
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - Apr 16th, 2026 6:30 am
CDT Notes Sarborg Publication of PRISM Framework Expanding AI - Apr 7th, 2026 6:30 am
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings - Mar 26th, 2026 6:30 am
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy - Mar 23rd, 2026 6:30 am
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - Mar 18th, 2026 6:30 am
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - Mar 12th, 2026 6:30 am
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent - Mar 5th, 2026 6:30 am
CDT Positions for Transformational Growth - Mar 4th, 2026 6:30 am
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals - Feb 24th, 2026 6:30 am
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy - Feb 20th, 2026 6:30 am